Literature DB >> 4118210

Throat infection and rash associated with an unusual Corynebacterium.

W J Ryan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4118210     DOI: 10.1016/s0140-6736(72)92782-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Coryneform bacteria in infectious diseases: clinical and laboratory aspects.

Authors:  M B Coyle; B A Lipsky
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

2.  Disclosure of reports.

Authors: 
Journal:  Br Med J       Date:  1973-11-03

3.  The lowly diphtheriod: nondiphtheria corynebacterial infections in humans.

Authors: 
Journal:  West J Med       Date:  1982-07

4.  Corynebacterium haemolyticum infections in Sri Lanka.

Authors:  R S Wickremesinghe
Journal:  J Hyg (Lond)       Date:  1981-10

5.  Peritonsillar abscess associated with Corynebacterium hemolyticum.

Authors:  R A Miller; F Brancato
Journal:  West J Med       Date:  1984-03

6.  Septicaemia due to Corynebacterium haemolyticum.

Authors:  R S Jobanputra; C P Swain
Journal:  J Clin Pathol       Date:  1975-10       Impact factor: 3.411

7.  Nonstreptococcal pharyngitis.

Authors:  Michael Green
Journal:  Semin Pediatr Infect Dis       Date:  2006-06-03

8.  Effects of media, atmosphere, and incubation time on colonial morphology of Arcanobacterium haemolyticum.

Authors:  L A Cummings; W K Wu; A M Larson; S E Gavin; J S Fine; M B Coyle
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

9.  Arcanobacterium haemolyticum phospholipase D is genetically and functionally similar to Corynebacterium pseudotuberculosis phospholipase D.

Authors:  W A Cuevas; J G Songer
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

Review 10.  Two cases of Actinomyces pyogenes infection in humans.

Authors:  M Drancourt; O Oulès; V Bouche; Y Peloux
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.